Alpine Bank Wealth Management’s AbbVie ABBV Stock Holding History

Alpine Bank Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.64M	Sell	18,449 -237	-1%	-$51K	0.6%	33
2026 Q1	$4.06M	Buy	18,686 +530	+3%	+$118K	0.59%	28
2025 Q4	$4.15M	Sell	18,156 -24	-0.1%	-$5.47K	0.59%	28
2025 Q3	$4.21M	Buy	18,180 +14	+0.1%	+$2.85K	0.59%	27
2025 Q2	$3.37M	Sell	18,166 -347	-2%	-$64.5K	0.51%	31
2025 Q1	$3.88M	Buy	+18,513	New	+$3.6M	0.62%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alpine Bank Wealth Management's ABBV Position: Q2 2026 in Review

Alpine Bank Wealth Management reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $51K and leaving 18,449 shares worth $4.64M. The position accounts for 0.6% of the portfolio, ranked #33.

Alpine Bank Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alpine Bank Wealth Management held 18,449 shares of AbbVie worth $4.64M as of Q2 2026.
Alpine Bank Wealth Management sold 237 AbbVie shares in Q2 2026, an estimated $51K.
AbbVie made up 0.6% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #33 holding.
Alpine Bank Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.